ArticleHIV research & clinical practice2025
Disparities in screening, diagnosis, and treatment of diabetes mellitus among people with HIV at a large southeastern academic health center.
Article in HIV research & clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPeople with HIV can survive decades on antiretroviral therapy (ART), but an increasing burden of metabolic disease, including diabetes mellitus (DM), threatens these gains. Prior studies found race and sex disparities in HIV treatment outcomes, but data on comorbid conditions remains scarce. We assessed whether disparities by race, sex, body mass index (BMI), and other factors existed in DM screening, incidence, and treatment outcomes in a large HIV care center in the southeastern US.
methodsWe conducted a retrospective analysis of people with HIV enrolled at the Vanderbilt Comprehensive Care Clinic between 2007-2022 on ART without prevalent DM. We assessed factors associated with DM screening by hemoglobin A1c (HbA1c), DM diagnosis, treatment, and achieving HbA1c ≤7.0%. We used modified Poisson regression to estimate adjusted risk ratios (RRs) to achieve the next step of the care continuum.
resultsOlder, Black, and overweight or obese people with HIV were more likely to be screened (range of RRs = 1.0-1.1,
conclusionsOlder, Black, and overweight/obese people with HIV were more likely to be screened and diagnosed with DM by their HIV care providers. However, age, BMI, and sex did not affect the initiation of DM medications or achieving A1c goals in this cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.